These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 36066980)
1. Thy-1 plays a pathogenic role and is a potential biomarker for skin fibrosis in scleroderma. Marangoni RG; Datta P; Paine A; Duemmel S; Nuzzo M; Sherwood L; Varga J; Ritchlin C; Korman BD JCI Insight; 2022 Oct; 7(19):. PubMed ID: 36066980 [TBL] [Abstract][Full Text] [Related]
2. Soluble Thy-1 reverses lung fibrosis via its integrin-binding motif. Tan C; Jiang M; Wong SS; Espinoza CR; Kim C; Li X; Connors E; Hagood JS JCI Insight; 2019 Nov; 4(21):. PubMed ID: 31672942 [TBL] [Abstract][Full Text] [Related]
3. Thy-1 interaction with Fas in lipid rafts regulates fibroblast apoptosis and lung injury resolution. Liu X; Wong SS; Taype CA; Kim J; Shentu TP; Espinoza CR; Finley JC; Bradley JE; Head BP; Patel HH; Mah EJ; Hagood JS Lab Invest; 2017 Mar; 97(3):256-267. PubMed ID: 28165468 [TBL] [Abstract][Full Text] [Related]
4. Latent transforming growth factor-beta-binding protein-4 regulates transforming growth factor-beta1 bioavailability for activation by fibrogenic lung fibroblasts in response to bleomycin. Zhou Y; Koli K; Hagood JS; Miao M; Mavalli M; Rifkin DB; Murphy-Ullrich JE Am J Pathol; 2009 Jan; 174(1):21-33. PubMed ID: 19056849 [TBL] [Abstract][Full Text] [Related]
5. Thy-1 depletion and integrin β3 upregulation-mediated PI3K-Akt-mTOR pathway activation inhibits lung fibroblast autophagy in lipopolysaccharide-induced pulmonary fibrosis. Wan H; Xie T; Xu Q; Hu X; Xing S; Yang H; Gao Y; He Z Lab Invest; 2019 Nov; 99(11):1636-1649. PubMed ID: 31249375 [TBL] [Abstract][Full Text] [Related]
6. Altered Dermal Fibroblasts in Systemic Sclerosis Display Podoplanin and CD90. Nazari B; Rice LM; Stifano G; Barron AM; Wang YM; Korndorf T; Lee J; Bhawan J; Lafyatis R; Browning JL Am J Pathol; 2016 Oct; 186(10):2650-64. PubMed ID: 27565038 [TBL] [Abstract][Full Text] [Related]
7. Neuropeptide Cortistatin Regulates Dermal and Pulmonary Fibrosis in an Experimental Model of Systemic Sclerosis. Barriga M; Benitez R; Robledo G; Caro M; O'Valle F; Campos-Salinas J; Delgado M Neuroendocrinology; 2022; 112(8):784-795. PubMed ID: 34649259 [TBL] [Abstract][Full Text] [Related]
8. Thy-1 expression regulates the ability of rat lung fibroblasts to activate transforming growth factor-beta in response to fibrogenic stimuli. Zhou Y; Hagood JS; Murphy-Ullrich JE Am J Pathol; 2004 Aug; 165(2):659-69. PubMed ID: 15277239 [TBL] [Abstract][Full Text] [Related]
9. Hypoxia-induced DNA hypermethylation in human pulmonary fibroblasts is associated with Thy-1 promoter methylation and the development of a pro-fibrotic phenotype. Robinson CM; Neary R; Levendale A; Watson CJ; Baugh JA Respir Res; 2012 Aug; 13(1):74. PubMed ID: 22938014 [TBL] [Abstract][Full Text] [Related]
10. Growth differentiation factor 15, a marker of lung involvement in systemic sclerosis, is involved in fibrosis development but is not indispensable for fibrosis development. Lambrecht S; Smith V; De Wilde K; Coudenys J; Decuman S; Deforce D; De Keyser F; Elewaut D Arthritis Rheumatol; 2014 Feb; 66(2):418-27. PubMed ID: 24504814 [TBL] [Abstract][Full Text] [Related]
11. Th17 cells and IL-17 promote the skin and lung inflammation and fibrosis process in a bleomycin-induced murine model of systemic sclerosis. Lei L; Zhao C; Qin F; He ZY; Wang X; Zhong XN Clin Exp Rheumatol; 2016; 34 Suppl 100(5):14-22. PubMed ID: 26750756 [TBL] [Abstract][Full Text] [Related]
12. Thy-1 promoter hypermethylation: a novel epigenetic pathogenic mechanism in pulmonary fibrosis. Sanders YY; Pardo A; Selman M; Nuovo GJ; Tollefsbol TO; Siegal GP; Hagood JS Am J Respir Cell Mol Biol; 2008 Nov; 39(5):610-8. PubMed ID: 18556592 [TBL] [Abstract][Full Text] [Related]
13. Dipeptidylpeptidase 4 as a Marker of Activated Fibroblasts and a Potential Target for the Treatment of Fibrosis in Systemic Sclerosis. Soare A; Györfi HA; Matei AE; Dees C; Rauber S; Wohlfahrt T; Chen CW; Ludolph I; Horch RE; Bäuerle T; von Hörsten S; Mihai C; Distler O; Ramming A; Schett G; Distler JHW Arthritis Rheumatol; 2020 Jan; 72(1):137-149. PubMed ID: 31350829 [TBL] [Abstract][Full Text] [Related]
14. The involvement of leucine-rich α-2 glycoprotein in the progression of skin and lung fibrosis in bleomycin-induced systemic sclerosis model. Nakajima H; Nakajima K; Serada S; Fujimoto M; Naka T; Sano S Mod Rheumatol; 2021 Nov; 31(6):1120-1128. PubMed ID: 33535851 [TBL] [Abstract][Full Text] [Related]
15. CD109 overexpression ameliorates skin fibrosis in a mouse model of bleomycin-induced scleroderma. Vorstenbosch J; Al-Ajmi H; Winocour S; Trzeciak A; Lessard L; Philip A Arthritis Rheum; 2013 May; 65(5):1378-83. PubMed ID: 23436317 [TBL] [Abstract][Full Text] [Related]
16. Loss of fibroblast Thy-1 expression correlates with lung fibrogenesis. Hagood JS; Prabhakaran P; Kumbla P; Salazar L; MacEwen MW; Barker TH; Ortiz LA; Schoeb T; Siegal GP; Alexander CB; Pardo A; Selman M Am J Pathol; 2005 Aug; 167(2):365-79. PubMed ID: 16049324 [TBL] [Abstract][Full Text] [Related]
17. Increased expression of latent TGF-β-binding protein 4 affects the fibrotic process in scleroderma by TGF-β/SMAD signaling. Lu J; Liu Q; Wang L; Tu W; Chu H; Ding W; Jiang S; Ma Y; Shi X; Pu W; Zhou X; Jin L; Wang J; Wu W Lab Invest; 2017 May; 97(5):591-601. PubMed ID: 28263294 [TBL] [Abstract][Full Text] [Related]